BIOTECHNOLOGY ADVANCES is a premier, peer-reviewed journal published by PERGAMON-ELSEVIER SCIENCE LTD, dedicated to advancing knowledge in the rapidly evolving fields of biotechnology and bioengineering. With an ISSN of 0734-9750 and an E-ISSN of 1873-1899, this esteemed journal covers a wide spectrum of topics relevant to applied microbiology, molecular biology, and biochemical innovation. Recognized for its academic rigor, it holds a distinguished position in the top quartile (Q1) in multiple categories, including Applied Microbiology and Biotechnology, Bioengineering, and Biotechnology, further evidenced by its high rankings in Scopus, where it ranks #3/127 in Applied Microbiology and Biotechnology and #7/311 in Biotechnology. Researchers and professionals in the field value the journal not only for its comprehensive coverage of cutting-edge research but also for its commitment to disseminating critical findings and fostering collaboration. While BIOTECHNOLOGY ADVANCES currently operates under a subscription model, its potential impact on future innovations in biotechnology cannot be overstated, making it an essential resource for anyone interested in the forefront of biotechnological advancements.

JOURNAL OF INDUSTRIAL MICROBIOLOGY & BIOTECHNOLOGY, published by Oxford University Press, is a vital resource for researchers and professionals actively engaged in the fields of applied microbiology, biotechnology, and bioengineering. With an ISSN of 1367-5435 and E-ISSN of 1476-5535, this journal has established itself as a leading platform for disseminating innovative research findings and advancing knowledge in industrial microbiology since its inception in 1996. As of 2023, it is classified in the Q2 quartile across multiple categories including Applied Microbiology and Biotechnology, Bioengineering, and Medicine, underscoring its significance in the academic community. Notably, it ranks 26th of 127 in Applied Microbiology and Biotechnology, placing it in the 79th percentile, indicative of its high impact and influence. Although it does not currently offer Open Access, it remains a key outlet for high-quality scholarly articles that align with the objectives of improving industrial practices through biotechnological applications. For those interested in the latest developments and methodologies within the realm of applied microbiology and biotechnology, this journal serves as an indispensable reference.

Applied Biological Chemistry, published by SPRINGER SINGAPORE PTE LTD, is a premier open access journal that has been serving the biological sciences community since 2016. With an ISSN of 2468-0834 and E-ISSN of 2468-0842, this journal is committed to disseminating high-quality research in the fields of Biochemistry, Genetics, Molecular Biology, and Organic Chemistry. The journal holds a commendable position within the scientific community, ranking in the Q2 quartile for both Biochemistry and Organic Chemistry niches as of 2023. It aims to foster innovative research and facilitate discussions that propel the understanding of complex biochemical processes and molecular techniques. By providing open access to its contents, Applied Biological Chemistry ensures that valuable research is readily available to researchers, professionals, and students globally, encouraging collaboration and knowledge sharing in this rapidly evolving discipline. Its pivotal role in enhancing scientific communication in the Netherlands and beyond is further underscored by a steadily increasing impact in the academic arena.

BIOLOGICAL CHEMISTRY, published by WALTER DE GRUYTER GMBH, is a premier journal based in Germany focusing on the ever-evolving fields of Biochemistry, Clinical Biochemistry, and Molecular Biology. With a robust reputation reflected in its top quartile rankings (Q1) within both Biochemistry and Clinical Biochemistry categories, and a commendable Q2 ranking in Molecular Biology for 2023, this journal stands as a vital resource for researchers, professionals, and students alike. The journal spans a rich history dating back to 1881 and embraces contemporary scientific discourse, ensuring accessibility to critical findings and advances that shape the biological sciences. Although it is not an open-access journal, its impactful contributions and relevant insights continue to serve the academic community. With its ISSN 1431-6730 and E-ISSN 1437-4315, BIOLOGICAL CHEMISTRY remains committed to fostering a deeper understanding of chemical processes in biological systems, driving innovation and research excellence into the future.

New Biotechnology, published by Elsevier, is a distinguished academic journal focused on the innovative realms of biotechnology and bioengineering. With an impact factor reflecting its strong presence in the field, this journal serves as a vital resource for researchers and professionals in the life sciences, offering insights into cutting-edge advancements and applications in biotechnology, molecular biology, and related disciplines. The journal's open access policy enhances its accessibility, allowing broad dissemination of knowledge and research findings. With a robust set of Scopus ranks placing it in the top tiers of its categories, including rank #36 in Biotechnology and #24 in Bioengineering, New Biotechnology represents a critical platform for scholars aiming to contribute to the ongoing dialogue in these rapidly evolving fields. Since its inception in 2008 and continuing through to 2024, the journal remains committed to fostering innovation and collaboration among scientists dedicated to advancing biotechnological applications, thereby significantly impacting medicine and industry.

BMC Biotechnology, a leading journal in the field of biotechnology, is published by BMC and has been a pivotal platform for open-access research since 2000. With a focus on the diverse areas of biotechnology, including biochemistry, genetics, and molecular biology, this journal holds a prestigious Q2 ranking in its category for 2023 and demonstrates a commendable percentile rank in the top 66th for its Scopus listings. Operating out of the United Kingdom and covering research from 2001 to 2024, BMC Biotechnology is committed to disseminating high-quality, rigorously peer-reviewed articles that foster advancements and innovations in the biotechnology landscape. Researchers, professionals, and students alike will benefit from the journal's rich content and dedicated commitment to enhancing scientific discourse within the realm of biotechnology.

MOLECULAR BIOTECHNOLOGY, published by SPRINGERNATURE, is a pivotal journal in the fields of applied microbiology, molecular biology, biochemistry, and biotechnology. Since its inception in 1994, the journal has aimed to disseminate high-quality research that explores the intersection of molecular biology and technology, fostering advancements in biotechnology applications. With an ISSN of 1073-6085 and an E-ISSN of 1559-0305, it has established itself as a significant contributor to the scientific community, currently holding a Q3 ranking across multiple categories including Applied Microbiology & Biotechnology and Biochemistry in the 2023 metrics. Although not an open access publication, the journal remains accessible through various institutional subscriptions, providing valuable insights and findings to researchers and professionals. Given its ongoing commitment to quality and relevance, MOLECULAR BIOTECHNOLOGY serves as an essential resource for those involved in cutting-edge research and innovation in molecular biotechnology and related disciplines.

JOURNAL OF GENERAL AND APPLIED MICROBIOLOGY, published by the MICROBIOL RES FOUNDATION, is a vital resource in the fields of applied microbiology and biotechnology, as well as in diverse medical applications, serving an academic community dedicated to advancing microbial science. Established in 1955, this journal has a rich history of disseminating innovative research and insights into the intricate world of microorganisms. With an ISSN of 0022-1260 and an E-ISSN of 1349-8037, the journal maintains high scholarly standards and robustness, reflected in its 2023 Scopus rankings placing it in the Q3 and Q4 quartiles within its categories. While primarily based in Japan, the journal engages a global audience, offering valuable contributions that inform both theoretical perspectives and practical applications in microbiology. Despite being a non-open-access publication, it provides pivotal research findings essential for academics, professionals, and students alike, fostering a deeper understanding of microbial impact on health and the environment.

CRITICAL REVIEWS IN BIOTECHNOLOGY, published by Taylor & Francis Ltd, stands as a leading journal in the field of biotechnology, consistently recognized for its rigorous peer-reviewed articles that impact the disciplines of Applied Microbiology, Biotechnology, and Medicine. With an impressive Q1 ranking in these categories and a significant influence reflected in its Scopus rankings—placing it within the top 5% of Applied Microbiology and the top 4% of Biotechnology journals—the journal serves as an essential resource for researchers, professionals, and students alike. Launched in 1983 and extending its coverage to encompass groundbreaking findings through 2024, it provides a rich forum for insightful reviews and innovative research that propel the field forward. Though not an Open Access journal, CRITICAL REVIEWS IN BIOTECHNOLOGY remains a vital point of reference for ongoing developments, critical analyses, and emerging trends, making it indispensable for those seeking to stay at the forefront of biotechnological advancements.

The Electronic Journal of Biotechnology is a premier Open Access journal published by Pontificia Universidad Catolica de Valparaiso, Chile, dedicated to advancing the fields of applied microbiology and biotechnology. With its inception in 1998 and an unwavering commitment to sharing knowledge, the journal has garnered a respectable ranking within the Q3 quartile for both its biotechnology and applied microbiology categories as of 2023, reflecting its significance in the academic community. Researchers and professionals will find its editorial rigor complemented by a robust platform for disseminating innovative findings, fostering collaboration, and driving forward biotechnology discussions. Given its inclusive approach, having transitioned to Open Access in 2014, the journal ensures that research is accessible to a global audience, making it a valuable resource for students, academics, and industry practitioners alike. Through the publication of original research, reviews, and critical insights, the Electronic Journal of Biotechnology aims to bridge the gap between scientific discovery and practical application, ultimately contributing to advancements in health, agriculture, and environmental sustainability.